Trastuzumab-deruxtecan (T-DXd) is a novel antibody drug conjugate that has improved treatment outcomes in patients with ... of drug-induced pneumonitis but was found to have pneumocystis jirovecii ...

Grade ≥3 treatment-emergent adverse events of ... Consider prophylaxis for herpes simplex virus, pneumocystis jirovecii pneumonia, and other infections according to standard of care in patients ...

Many debunked stereotypes about HIV and AIDS still existed and there was no good antiretroviral treatment readily available ... other deadly opportunistic infections include Pneumocystis jirovecii ...

Grade ≥3 treatment-emergent adverse events of interest (AEIs ... Consider prophylaxis for herpes simplex virus, pneumocystis jirovecii pneumonia, and other infections according to standard of care in ...

The first-line treatment for this syndrome is to surgically remove ... can lead to a health-related emergency (15, 16). In particular, Pneumocystis jirovecii pneumonia (PCP) may occur in patients with ...

The patient received 3 days of 1 g intravenous methylprednisolone, followed by 60 mg daily oral prednisolone (weight 78.7 kg), with trimethoprim-sulfamethoxazole 160/800 mg three times a week given as ...

5-year follow-up from SEQUOIA study demonstrated treatment with BRUKINSA reduced the risk of progression or death by 71% compared to bendamustine-rituximab in patients with treatment-naïve CLL ...

“This condition has a high mortality rate, so timely and effective treatment is crucial for ... another deadly respiratory disease, pneumocystis pneumonia 6, a fungal infection of the lungs.

The study identified Candida spp. (17.89%), Mucorales (13.01%), Aspergillus spp. (8.94%), and Pneumocystis jirovecii (6.5%) as the most common pathogens. Alarmingly, the attributable mortality rate ...

Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...